Oxford Cancer Analytics

Healthcare & Life Sciences

Recent Finacing

Series A

Recent Raise

$11M

Oxford Cancer Analytics (OXcan) develops minimally invasive liquid biopsy blood tests for early lung cancer detection using advanced proteomics and AI.

Total Funding

$11M

Headquarters

Oxford, United Kingdom

Founded

N/A

Website

oxcan.org

Focus Areas

Medtech

Liquid Biopsy

Lung Cancer Detection

Proteomics

Blood Tests

Investors